HENGCAI Unveils Strategic Expansion at Medical Fair India 2026, Targeting Growth in India’s Imaging Solutions Market
HENGCAI, a global leader in medical imaging film manufacturing, has officially launched its campaign to capture a larger share of India’s rapidly growing healthcare sector at the Medical Fair India 2026, held in Mumbai from March 10–12, 2026. The company’s participation underscores its commitment to introducing cutting-edge imaging solutions, including medical thermal dry image film, inkjet film, medical laser film, and x-ray film, tailored to meet the evolving demands of Indian healthcare providers.
With India’s medical imaging market projected to grow at a CAGR of 8.5% through 2030, driven by rising chronic diseases and infrastructure modernization, HENGCAI aims to position itself as a key supplier of high-performance, cost-effective imaging media. The company’s booth (Hall 1, Stand B24) showcases a full suite of products designed for compatibility with leading diagnostic equipment, emphasizing durability, clarity, and environmental sustainability—a priority for Indian hospitals transitioning to green healthcare practices.
Medical Thermal Dry Image Film: A Game-Changer for Rapid Diagnostics
HENGCAI’s medical thermal dry image film has garnered attention for its instant drying capability, eliminating the need for chemical processing and reducing turnaround times in busy radiology departments. This product is particularly suited for India’s tier-2 and tier-3 cities, where access to advanced imaging infrastructure remains limited. By partnering with local distributors, HENGCAI plans to deploy this technology across 500+ diagnostic centers in the next 18 months, targeting a 15% market share in the dry film segment.
Inkjet Film and Medical Laser Film: Precision Meets Versatility
The company’s inkjet film and medical laser film cater to specialized applications, from pediatric imaging to dental diagnostics. HENGCAI’s inkjet film offers ultra-high resolution, ensuring minute details are captured in color-coded reports, while its laser film provides unmatched density and contrast for complex CT and MRI scans. “Indian clinicians demand precision without compromising on speed,” said Rajesh Mehta, HENGCAI’s Regional Sales Director for South Asia. “Our films deliver both, backed by a 24-month warranty—a first in the Indian market.”
X-Ray Film: Reinventing a Classic for Modern Needs
Despite the digital shift, x-ray film remains indispensable in India, where 60% of rural hospitals rely on analog systems. HENGCAI’s latest x-ray film formulation reduces radiation exposure by 30% while maintaining image quality, addressing safety concerns in high-volume settings. The product’s compatibility with both conventional and digital x-ray machines makes it a transitional solution for facilities upgrading their equipment.
Strategic Partnerships to Drive Adoption
To accelerate market penetration, HENGCAI has signed agreements with three leading Indian distributors: MedTech Solutions, Apollo Imaging Supplies, and Radiology First. These partnerships will streamline supply chains, ensuring 95% of orders are fulfilled within 48 hours—a critical factor in India’s time-sensitive healthcare environment. Additionally, HENGCAI is offering free training workshops for technicians at its booth, demonstrating best practices for handling and storing imaging films to maximize shelf life.
Sustainability as a Competitive Edge
HENGCAI’s products align with India’s National Health Policy 2027, which emphasizes reducing medical waste. The company’s medical thermal dry image film and x-ray film are 100% recyclable, while its packaging uses biodegradable materials. “Sustainability isn’t just a trend; it’s a responsibility,” said Mehta. “By 2027, HENGCAI aims to divert 500 tons of plastic waste annually through its eco-friendly initiatives in India.”
Early Success at Medical Fair India 2026
On the exhibition’s first day, HENGCAI secured orders worth INR 2.5 crore (approximately USD 300,000) from 12 hospitals and clinics. The company’s interactive demo stations, featuring live comparisons of its films against competitors, attracted over 500 visitors, including radiologists, procurement managers, and government health officials. “The feedback has been overwhelming,” said Mehta. “Many clients praised our films’ cost-to-performance ratio, which is 20% better than incumbent brands.”